Targeted Marrow Irradiation, Fludarabine Phosphate, and Busulfan Before Donor Progenitor Cell Transplant in Treating Patients With Hematologic Malignancies

Clinical trial NCT02129582 · COMPLETED

Trial details

NCT number: NCT02129582
Sponsor: Case Comprehensive Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Hematologic Malignancies Acute Lymphocytic Leukemia Non Hodgkin Lymphoma Hodgkin Lymphoma Multiple Myeloma Myelodysplastic Syndrome Chronic Lymphocytic Leukemia Chronic Myeloid Leukemia Myelofibrosis Myeloproliferative Syndrome

Start date: 2014-11-05
Primary completion: 2019-03-15
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.